These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The term sheet tango. Willey T; Parsigian D Nat Biotechnol; 2003 Jul; 21 Suppl():BE29-30. PubMed ID: 12874974 [No Abstract] [Full Text] [Related]
13. Shareholders flex their muscles. Thiel K Nat Biotechnol; 2008 Jan; 26(1):19-21. PubMed ID: 18183007 [No Abstract] [Full Text] [Related]
14. Is Elan a turnaround? Jacobs T Nat Biotechnol; 2003 Sep; 21(9):985. PubMed ID: 12949557 [No Abstract] [Full Text] [Related]
15. My worst biotech investment. Jacobs T Nat Biotechnol; 2006 Apr; 24(4):401. PubMed ID: 16601718 [No Abstract] [Full Text] [Related]
16. Biotechs for pennies? Jacobs T Nat Biotechnol; 2004 Dec; 22(12):1509. PubMed ID: 15583652 [No Abstract] [Full Text] [Related]
17. Public markets show signs of life. Mitchell P Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181 [No Abstract] [Full Text] [Related]
18. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
19. This means war. Nat Biotechnol; 2008 Sep; 26(9):954. PubMed ID: 18779784 [TBL] [Abstract][Full Text] [Related]
20. UK bidding war amidst merger mania. Mitchell P Nat Biotechnol; 2003 Apr; 21(4):343-4. PubMed ID: 12665805 [No Abstract] [Full Text] [Related] [Next] [New Search]